Treatment of sarcopenia by antagonists of myostatin
Sarcopenia is a profound loss of skeletal muscle mass, strength, and endurance that occurs with aging. Age-related muscle wasting has been reported even among healthy, physically active individual and the rate of muscle loss has been approximated to range 1-2% annually past the age of 50. Albeit, ex...
Saved in:
Main Author: | Anissa Anindya Widjaja |
---|---|
Other Authors: | Ravi Kambadur |
Format: | Theses and Dissertations |
Language: | English |
Published: |
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/10356/53912 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Screening and characterization of potential small molecule antagonists of myostatin.
by: Lee, Rachel Hui Min.
Published: (2012) -
Role of Myostatin in oxidative stress in skeletal muscle
by: Sandhya Sriram
Published: (2013) -
Characterisation of ant-1 as an inhibitor of myostatin activity.
by: Irfana Begum Ikbal.
Published: (2011) -
Regulation of muscle metabolism by myostatin
by: Zhang, Chen
Published: (2012) -
[Withdrawn] Regulation of insulin resistance by myostatin
by: Sabeera Bonala
Published: (2013)